| Pharmaceuticals Industry | Healthcare Sector | Mr. Tao Wang CEO | XSHE Exchange | CNE100001096 ISIN |
| CN Country | 2,125 Employees | 28 May 2026 Last Dividend | 4 Mar 2014 Last Split | 22 Feb 2011 IPO Date |
Zhejiang Jolly Pharmaceutical Co.,LTD, established in 1995 and headquartered in Huzhou, the People's Republic of China, is a pioneering company dedicated to the research, production, and international marketing of Chinese medicinal products. Initially founded as Zhejiang Jolly Pharmaceutical Health Products Co., LTD, it underwent a name change in 1998 to better reflect its broadened scope and commitment to advancing traditional Chinese medicine. The company is deeply involved in the medical services sector, notably through its investments and participations in the medical operations of Deqing No.3 People's Hospital. With a rich history and a robust product portfolio, Zhejiang Jolly Pharmaceutical Co.,LTD stands at the forefront of integrating traditional Chinese medicinal solutions with modern healthcare services.
Designed to tackle a range of symptoms including insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, giddy tinnitus, and other symptoms associated with the disharmony of heart and kidney or neurasthenia. This capsule is a representation of the company's commitment to addressing complex health issues with nuanced herbal formulations.
A solution for those suffering from urinary difficulties and discomforts such as frequent urination, dysuria, weak steam of urine, endless urine, as well as soreness and weakness of waist and knees. These symptoms are often caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis, and Lingze Tablet offers a targeted treatment option.
Utilized as an adjuvant therapy, the Bailing Tablet can assist in the treatment of cough, asthma, back pain, and chronic bronchitis that are rooted in the deficiency of lungs and kidney. Through its unique composition, this tablet aids in alleviating chronic respiratory and back issues.
Addressing the multifaceted symptoms of perimenopausal syndrome or disharmony of heart and kidney, such as sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, along with weak pulse. This product exemplifies how traditional Chinese medicine interprets and addresses complex syndromes.
The company extends its healthcare solutions with a range of pharmaceutical injections including azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside. These injections cater to various acute and chronic conditions, demonstrating Zhejiang Jolly Pharmaceutical's versatility in product offerings.
In addition to finished medicinal products, Zhejiang Jolly Pharmaceutical also specializes in the production and supply of critical raw materials such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. These materials are foundational to several of the company's proprietary formulations as well as to the broader market of Chinese medicinal products.